Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Csaba Farsang"'
Autor:
János Nemcsik, Johanna Takács, Dorottya Pásztor, Csaba Farsang, Attila Simon, Dénes Páll, Péter Torzsa, Szilveszter Dolgos, Akos Koller, Norbert Habony, Zoltán Járai
Publikováno v:
Blood Pressure, Vol 33, Iss 1 (2024)
AbstractPurpose Hypertension is a major public health problem, thus, its timely and appropriate diagnosis and management are crucial for reducing cardiovascular morbidity and mortality. The aim of the new Hungarian Hypertension Registry is to evaluat
Externí odkaz:
https://doaj.org/article/72147fb7c77045f2b61b3453349970a2
Autor:
Scott J Denardo, Yan Gong, Rhonda M Cooper-DeHoff, Csaba Farsang, Matyas Keltai, László Szirmai, Franz H Messerli, Anthony A Bavry, Eileen M Handberg, Giuseppe Mancia, Carl J Pepine
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157212 (2016)
[This corrects the article DOI: 10.1371/journal.pone.0122726.].
Externí odkaz:
https://doaj.org/article/23444140101e4bd2bca74ff2e4731bce
Autor:
Scott J Denardo, Yan Gong, Rhonda M Cooper-DeHoff, Csaba Farsang, Matyas Keltai, László Szirmai, Franz H Messerli, Anthony A Bavry, Eileen M Handberg, Giuseppe Mancia, Carl J Pepine
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0122726 (2015)
Elevated nighttime blood pressure (BP) and heart rate (HR), increased BP and HR variability, and altered diurnal variations of BP and HR (nighttime dipping and morning surge) in patients with systemic hypertension are each associated with increased a
Externí odkaz:
https://doaj.org/article/254fec39511f480cbfc333de6ab68b58
Autor:
János, NEMCSIK, Johanna, TAKÁCS, Dorottya, PÁSZTOR, Csaba, FARSANG, Attila, SIMON, Dénes, PÁLL, Péter, TORZSA, Szilveszter, DOLGOS, Ákos, KOLLER, Norbert, HABONY, Zoltán, JÁRAI
Publikováno v:
Hypertonia és Nephrologia; 2024, Vol. 28 Issue 4, p152-158, 7p
Autor:
Csaba Farsang
Publikováno v:
Lege Artis Medicinae. 32:427-433
A közleményben összefoglalom a hypertoniás betegek gyógyszeres kezelésére, és külön fejezetrészben a hypertoniás sürgősségi állapotokra vonatkozó jelenleg érvényes gyógyszeres kezelési irányelveket.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d5a0e11bf2078f2b9a99661fa94ad19
https://doi.org/10.33616/lam.32.033
https://doi.org/10.33616/lam.32.033
Publikováno v:
Hypertonia és Nephrologia; 2023, Vol. 27 Issue 4, p180-184, 5p
Autor:
Martine de Champvallins, Yuri Karpov, Csaba András Dézsi, Csaba Farsang, M G Glezer, Romualda Brzozowska-Villatte
Publikováno v:
Advances in Therapy
Introduction To assess real-life effectiveness of a perindopril/indapamide (Per/Ind) single-pill combination (SPC) in patients with hypertension (HT) and type 2 diabetes mellitus (T2DM), obesity and/or metabolic syndrome (MetS). Methods This post hoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1061ea42df75b94e5804936be6a4b932
http://europepmc.org/articles/PMC8004479
http://europepmc.org/articles/PMC8004479
Autor:
Csaba Farsang
Publikováno v:
Lege Artis Medicinae. 31:193-199
Chronic obstructive pulmonary disease is a very common comorbidity of hypertension and it is often unrecognised by physicians. The factors involved in the pathomechanism of both diseases should be realised when choosing treatment. Among factors, hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb738a456a2b77600baa227b5a495993
https://doi.org/10.33616/lam.31.013
https://doi.org/10.33616/lam.31.013
Publikováno v:
Advances in Therapy. 38:479-494
Our objective was to determine the effectiveness of a perindopril/indapamide (Per/Ind) single-pill combination (SPC) in a broad range of patient profiles, including subgroups with varying hypertension severity, age and cardiovascular risk profiles. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cdb295999a370119406853d7ec75549
https://doi.org/10.1007/s12325-020-01527-3
https://doi.org/10.1007/s12325-020-01527-3
Autor:
Csaba Farsang
Publikováno v:
Lege Artis Medicinae. 30:575-580
Nonsteroidal antiinflammatory drugs (NSAIDs) are among the most frequently used pharmaceuticals. Nevertheless, a number of studies emphasized that NSAIDs were damaging not only the gastrointestinal (GI), but also the cardiovascular (CV) system, could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acf77435d5d568aa702bf7e9f8a3a1b8
https://doi.org/10.33616/lam.30.047
https://doi.org/10.33616/lam.30.047